Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Orgenesis, Cure Therapeutics Form JV | Contract Pharma

What are you searching for?

Sign in
Breaking News

Orgenesis, Cure Therapeutics Form JV

Aims to advance point-of-care development and commercialization of cell and gene therapies.

By: Contract Pharma

Contract Pharma Staff

Orgenesis, a global biotech company focused on cell and gene therapies (CGTs), and Cure Therapeutics, a developer of immuno-oncology and cell and gene therapies to target cancer and infectious diseases, signed a joint venture agreement.

The JV aims to advance the development, regulatory and commercialization of point of care production for both organizations’ cell and gene therapies and immunotherapies.

The companies will collaborate on developing and commercializing Cure Therapeutics’ pipeline on a global basis, as well as developing, commercializing and supplying Orgenesis’ therapeutic pipeline in South Korea and Japan. In connection with the agreement, each of Cure Therapeutics and Orgenesis will contribute at least $10 million to the joint venture to cover operating costs, $5 million of which may be provided in the form of in-kind contribution.

The first focus of the partnership will be aligning the efforts of both companies to advance proprietary Orgenesis CAR-T, TILS and DUVAC therapies into clinical trials in South Korea and Japan. Process development and validation will be completed by leveraging the POCare Technologies from the Orgenesis platform to achieve automated manufacturing at the point of care.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics